Also in human prostate cancer samples, the CYP1A1 enhancer was methylated in 11 out of 30 samples, while no methylation in the CYP1A1 promoter was detected in healthy control tissue [220] (Fig. 4E). This evidence concerns the gene CYP1A1 and prostate cancer.